Genetic conditions like Dravet syndrome are hard to tackle with traditional gene therapy. But new approaches are in the works.
Category: biotech/medical – Page 1,306
Alzheimer’s Proteins Reduced by Sleep Drug
Suvorexant (Belsomra), a dual orexin receptor antagonist approved for insomnia, reduced levels of tau phosphorylation and amyloid beta, a small clinical trialopens in a new tab or window showed.
The ratio of phosphorylated tau-threonine-181 (p-tau-181) to unphosphorylated tau-threonine-181 decreased 10% to 15% in cognitively normal adults treated with suvorexant 20 mg compared with placebo, reported Brendan Lucey, MD, MSCI, of Washington University School of Medicine in St. Louis, and co-authors.
Amyloid-beta levels fell 10% to 20% compared with placebo starting 5 hours after suvorexant administration, the researchers wrote in Annals of Neurologyopens in a new tab or window.
— Both amyloid and tau levels fell in early trial.
Warning: Common Synthetic Chemicals Disrupt Key Biological Processes — Linked to a Diverse Array of Diseases
Researchers from the Keck School of Medicine of USC have discovered that being exposed to a mixture of synthetic chemicals commonly present in the environment affects multiple crucial biological processes in both children and young adults. These processes include the metabolism of fats and amino acids.
<div class=””> <div class=””><br />Amino acids are a set of organic compounds used to build proteins. There are about 500 naturally occurring known amino acids, though only 20 appear in the genetic code. Proteins consist of one or more chains of amino acids called polypeptides. The sequence of the amino acid chain causes the polypeptide to fold into a shape that is biologically active. The amino acid sequences of proteins are encoded in the genes. Nine proteinogenic amino acids are called “essential” for humans because they cannot be produced from other compounds by the human body and so must be taken in as food.<br /></div> </div>
Neuronal activity shapes the development of astrocytes, shows study
Researchers at Baylor College of Medicine have unraveled the processes that give astrocytes, the most abundant glial cell in the brain, their special bushy shape, which is fundamental for brain function. They report in the journal Nature that neuronal activity is necessary and sufficient for astrocytes to develop their complex shape, and interrupting this developmental process results in disrupted brain function.
“Astrocytes play diverse roles that are vital for proper brain function,” said first author Yi-Ting Cheng, a graduate student in Dr. Benjamin Deneen’s lab at Baylor. “For instance, they support the activity of other essential brain cells, neurons; participate in the formation and function of synapses, or neuron-to-neuron connections; release neurotransmitters, chemicals that mediate neuronal communication; and make the blood-brain barrier.”
In the adult brain, the bushy shape of astrocytes is fundamentally linked to effective brain function. The ends of the branched-out astrocyte structure interact with neurons and regulate synaptic activity.
Unraveling the Genetic Mechanisms Behind Long-Lasting Memories in the Brain
Summary: Researchers shed new light on the molecular and genetic basis of long-term memory formation in the brain. A new study reveals a single stimulation to the synapses of hippocampal neurons triggered numerous cycles where the memory-coding Arc gene produced mRNA molecules that were then translated into synapse-strengthening Arc proteins. From the findings, researchers determined a novel feedback loop that helps explain how short-lived mRNA and proteins create long-term memories in the brain.
Source: albert einstein college of medicine.
Helping your mother make pancakes when you were three…riding your bike without training wheels…your first romantic kiss: How do we retain vivid memories of long-ago events?
Genetic Driver of Anxiety Discovered
Summary: An international team of scientists has identified a gene in the brain responsible for anxiety symptoms and found that modifying the gene can reduce anxiety levels, offering a novel drug target for anxiety disorders. The discovery highlights a new amygdala miR483-5p/Pgap2 pathway that regulates the brain’s response to stress and provides a potential therapeutic approach for anxiety disorders.
Source: University of Bristol.
A gene in the brain driving anxiety symptoms has been identified by an international team of scientists. Critically, modification of the gene is shown to reduce anxiety levels, offering an exciting novel drug target for anxiety disorders.
Scientists Use Electricity to Make Wounds Heal 3x Faster
Scientists have developed a specially engineered biochip that uses electricity to heal wounds up to three times faster than normal.
It’s well known that electric fields can guide the movements of skin cells, nudging them towards the site of an injury for instance. In fact, the human body generates an electric field that does this naturally. So researchers from the University of Freiburg in Germany set out to amplify the effect.
While it might not heal severe injuries with the speed of a Marvel superhero, it could radically reduce the time it takes for small tears and lacerations to recover.
Opinion letter from Ray Kurzweil on request for 6 month delay on large language models that go beyond GPT-4 « Kurzweil
Kurzweil says NO, on AI pause non sense.
By Ray Kurzweil April 2023
Regarding the Open Letter to “pause” research on AI “more powerful than GPT-4,” this criterion is too vague to be practical. And the proposal faces a serious coordination problem: those that agree to a pause may fall far behind corporations or nations that disagree. There are tremendous benefits to advancing AI in critical fields such as medicine and health, education, pursuit of renewable energy sources to replace fossil fuels, and scores of other fields. I didn’t sign, because I believe we can address the signers’ safety concerns in a more tailored way that doesn’t compromise these vital lines of research.
New study reveals a gel that promises to wipe out brain cancer for good
An anti-cancer gel promises to wipe out glioblastoma permanently, a feat that’s never been accomplished by any drug or surgery. So what makes this gel so special?
Scientists at Johns Hopkins University (JHU) have developed a novel gel that both eliminates brain cancer (glioblastoma) and keeps it from recurring. When they tested this anti-cancer gel on mice with glioblastoma, surprisingly, all the mouse models were cured of the illness.
“We don’t usually see 100% survival in mouse models of this disease,” said Betty Tyler, one of the study authors and a neurosurgery professor at the Johns Hopkins School of Medicine.